These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17197374)

  • 1. Importance of clinical diagnoses for comorbidity studies in substance use disorders.
    Torrens M; Martin-Santos R; Samet S
    Neurotox Res; 2006 Dec; 10(3-4):253-61. PubMed ID: 17197374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV.
    Torrens M; Serrano D; Astals M; Pérez-Domínguez G; Martín-Santos R
    Am J Psychiatry; 2004 Jul; 161(7):1231-7. PubMed ID: 15229056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers.
    Hasin DS; Trautman KD; Miele GM; Samet S; Smith M; Endicott J
    Am J Psychiatry; 1996 Sep; 153(9):1195-201. PubMed ID: 8780425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV.
    Hasin D; Samet S; Nunes E; Meydan J; Matseoane K; Waxman R
    Am J Psychiatry; 2006 Apr; 163(4):689-96. PubMed ID: 16585445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychiatric research interview for substance and mental disorders: phenomenologically based diagnosis in patients who abuse alcohol or drugs.
    Hasin D; Trautman K; Endicott J
    Psychopharmacol Bull; 1998; 34(1):3-8. PubMed ID: 9564191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comorbid mental disorders in substance users from a single catchment area--a clinical study.
    Langås AM; Malt UF; Opjordsmoen S
    BMC Psychiatry; 2011 Feb; 11():25. PubMed ID: 21314980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychiatric emergencies (part II): psychiatric disorders coexisting with organic diseases.
    Testa A; Giannuzzi R; Sollazzo F; Petrongolo L; Bernardini L; Dain S
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():65-85. PubMed ID: 23436669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and patterns of "dual diagnosis" among psychiatric inpatients.
    Lehman AF; Myers CP; Corty E; Thompson JW
    Compr Psychiatry; 1994; 35(2):106-12. PubMed ID: 8187473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concordance between DSM-III-R and DSM-IV diagnoses of substance use disorders in adolescents.
    Mikulich SK; Hall SK; Whitmore EA; Crowley TJ
    Drug Alcohol Depend; 2001 Feb; 61(3):237-48. PubMed ID: 11164688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personality disorders in substance abusers: relation to substance use.
    Rounsaville BJ; Kranzler HR; Ball S; Tennen H; Poling J; Triffleman E
    J Nerv Ment Dis; 1998 Feb; 186(2):87-95. PubMed ID: 9484308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of independent depression and substance-induced depression in cannabis-, cocaine-, and opioid-dependent treatment seekers.
    Dakwar E; Nunes EV; Bisaga A; Carpenter KC; Mariani JP; Sullivan MA; Raby WN; Levin FR
    Am J Addict; 2011; 20(5):441-6. PubMed ID: 21838843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent versus substance-induced major depressive disorder in substance-dependent patients: observational study of course during follow-up.
    Nunes EV; Liu X; Samet S; Matseoane K; Hasin D
    J Clin Psychiatry; 2006 Oct; 67(10):1561-7. PubMed ID: 17107247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosing comorbidity: concepts, criteria, and methods.
    Samet S; Nunes EV; Hasin D
    Acta Neuropsychiatr; 2004 Feb; 16(1):9-18. PubMed ID: 26983872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual diagnosis screening interview to identify psychiatric comorbidity in substance users: development and validation of a brief instrument.
    Mestre-Pintó JI; Domingo-Salvany A; Martín-Santos R; Torrens M;
    Eur Addict Res; 2014; 20(1):41-8. PubMed ID: 23921461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic.
    Tsuang D; Cowley D; Ries R; Dunner DL; Roy-Byrne PP
    J Clin Psychiatry; 1995 Dec; 56(12):549-55. PubMed ID: 8530330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric comorbidity in forensic psychiatry.
    Palijan TZ; Muzinić L; Radeljak S
    Psychiatr Danub; 2009 Sep; 21(3):429-36. PubMed ID: 19794370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance use disorder: abuse, dependence and dyscontrol.
    Widiger TA; Smith GT
    Addiction; 1994 Mar; 89(3):267-82. PubMed ID: 8173493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance use problems and associated psychiatric symptoms among adolescents in primary care.
    Shrier LA; Harris SK; Kurland M; Knight JR
    Pediatrics; 2003 Jun; 111(6 Pt 1):e699-705. PubMed ID: 12777588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remission of substance use disorder among psychiatric inpatients with mental illness.
    Dixon L; McNary S; Lehman AF
    Am J Psychiatry; 1998 Feb; 155(2):239-43. PubMed ID: 9464204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Which psychiatric comorbidities in cannabis dependence during adolescence? Comparison of outpatients and controls].
    Dorard G; Bungener C; Phan O; Edel Y; Corcos M; Berthoz S
    Encephale; 2018 Feb; 44(1):2-8. PubMed ID: 27637871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.